MT-TP and metabolic dysfunction-associated steatotic liver disease: Numerous studies have highlighted, that genetic defects impairing hepatic VLDL secretion (APOB, APOC3, MTTP, TM6SF2) can lead to MASLD even in the absence of obesity or insulin resistance45–47.